| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5882911 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 10 Pages |
Abstract
The results of the present study support the use of elotuzumab for the treatment of patients with MM and renal dysfunction without dose adjustment.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Jesus Berdeja, Sundar Jagannath, Jeffrey Zonder, Ashraf Badros, Jonathan L. Kaufman, Robert Manges, Manish Gupta, Amol Tendolkar, Mark Lynch, Eric Bleickardt, Prashni Paliwal, Ravi Vij,